A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD.

NCT03580005 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped The study was cancelled prior to the enrollment of any participants.

Conditions

Attention Deficit Hyperactivity Disorder (ADHD)
Attention Deficit Hyperactivity Disorder

Interventions

DRUG: methylphenidate HCl ERCT
DRUG: Placebo

Sponsor

Pfizer